AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Edwards Lifesciences to present at J.P. Morgan Healthcare Conference.
ByAinvest
Tuesday, Jan 7, 2025 7:09 am ET1min read
Edwards Lifesciences Corporation will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Jan. 14, 2025. Bernard Zovighian, CEO, and Scott Ullem, CFO, will present. The live webcast of the presentation will be available on Edwards' investor relations website, with an archived version accessible later the same day. Edwards Lifesciences is a leading global structural heart innovation company, driven by a passion to improve patient lives.
Edwards Lifesciences Corporation (NYSE: EW), a leading global structural heart innovation company, is set to participate in the highly anticipated 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025. This esteemed event serves as a premier platform for companies to present their latest developments and future growth prospects to investors and industry experts.Bernard Zovighian, the company's CEO, and Scott Ullem, CFO, will represent Edwards Lifesciences during the conference. The presentation, scheduled for 11:15 a.m. PT, will be accessible via a live webcast on the company's investor relations website (http://ir.edwards.com/). An archived version of the webcast will also be available later the same day for those unable to attend the live presentation.
Edwards Lifesciences is renowned for its commitment to improving patient lives through groundbreaking technologies and strategic partnerships with healthcare stakeholders. The company's portfolio includes a diverse range of products designed to address various structural heart conditions, such as transcatheter aortic valve replacement (TAVR) systems and surgical heart valves.
According to a press release by Business Wire ([1]), Edwards Lifesciences is the global leader in structural heart innovation. The company's focus on developing life-changing innovations has positioned it as a key player in the healthcare industry. StockTitan further emphasizes this by stating that Edwards Lifesciences is "dedicated to delivering breakthrough technologies and maintaining partnerships with healthcare stakeholders to improve patient lives" ([2]).
As the company prepares to present at the J.P. Morgan Healthcare Conference, investors and stakeholders alike are eagerly anticipating updates on Edwards Lifesciences' latest innovations, growth strategies, and future prospects. The live webcast presentation offers an excellent opportunity for attendees to gain valuable insights into the company's plans and vision for the future.
References:
[1] Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference. (2025, January 7). BusinessWire. Retrieved from https://www.businesswire.com/news/home/20250107783243/en/
[2] Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference. (2025, January 7). StockTitan. Retrieved from https://www.stocktitan.net/news/EW/edwards-lifesciences-to-present-at-the-43rd-annual-j-p-morgan-q9cn3ea7rb1z.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet